Virus-receptor interactions of coxsakie B viruses and their putative influence on cardiotropism

Medical Microbiology and Immunology

Volumn 193, Issue 2-3, 2004, Pages 127-131

  Selinka, Hans Christoph ^a,b   Wolde, Antje ^b   Sauter, Martina ^b   Kandolf, Reinhard ^b   Klingel, Karin ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Coxsackie B viruses; Coxsackievirus adenovirus receptor; Decay accelerating factor; Myocarditis; Transcytosis; Virus receptor interactions

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR;

ARTICLE; COXSACKIE VIRUS B; ENDOTHELIUM; HEART FUNCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS MYOCARDITIS;

ANTIGENS, CD55; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HELA CELLS; HUMANS; MYOCARDITIS; MYOCARDIUM; RECEPTORS, VIRUS;

EID: 2542544236     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-003-0193-y     Document Type: Article

References (32)

1. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, Schnell FJ, Nusrat A, Parkos CA, Dermody TS (2001) Junction adhesion molecule is a receptor for reovirus. Cell 104:441-451
2. Bergelson, JM, Cunningham, JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwit, MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323
3. Bergelson, JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW (1997) Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175:697-700
4. Carson, SD, Chapman, NN, Tracy SM (1997) Purification of the putative coxsackievirus B receptor from HeLa cells. Biochem Biophys Res Commun 233:325-328
5. Cohen CJ, Shieh JTC, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM (2001) The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98:15191-15196
6. Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl JP (2002) Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci USA 99:9410-9414
7. Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, Krust B (2000) The cell-surface expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 261:312-328
8. Huber, M, Selinka, H-C, Kandolf R (1997) Tyrosine phosphorylation events during coxsackievirus B3 replication. J Virol 71:595-600
9. Huber M, Watson KA, Selinka H-C, Carthy CM, Klingel K, McManus BM, Kandolf R (1999) Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 73:3587-3594
10. Ito M, Kodama M, Masuko M, Yamaura M, Fuse K, Uesugi Y, Hirono S, Okura Y, Kato K, Hotta Y, Honda T, Kuwano R, Aizawa Y (2000) Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 86:275-280
11. Kandolf R, Klingel K, Zell R, Selinka H-C, Schneider-Brachert W, Bültmann B (1993) Molecular pathogenesis of enterovirus-induced myocarditis: Virus persistence and chronic inflammation. Intervirology 35:140-151
12. Klingel K, Rieger P, Mall G, Selinka H-C, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227-1237
13. Klingel K, Selinka H-C, Sauter M, Bock C-T, Szalay G, Kandolf R (2002) Molecular mechanisms in enterovirus- and parvovirus B19-associated myocarditis and inflammatory cardiomyopathy. Eur Heart J 4(Suppl I):8-12
14. Knowlton KU, Jeon E-S, Berkley N, Wessely R, Huber S (1996) A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811-7818
15. Liu PP. Mason JW (2001) Advances in the understanding of myocarditis. Circulation 104:1076-1082
16. Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Wilson JE, Yang D, McManus BM (2002) Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signalling pathway. J Virol 76:3365-3373
17. Martino TA, Liu P, Sole MJ (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74:182-188
18. Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP (1998) Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Virology 244:302-314
19. Nisole S, Krust B, Hovanessian AG (2002) Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res 276:155-173
20. 5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy. Implications for cardiotropic viral infections. Circulation 104:275-280
21. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561-1569
22. Ouzilou L, Caliot E, Pelletier I, Prevost MC, Pringault E, Colbere-Garapin F (2002) Poliovirus transcytosis through M-like cells. J Gen Virol 83:2177-2182
23. Pasch A, Kuepper JH, Wolde A, Kandolf R, Selinka H-C (1999) Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J Gen Virol 80:3153-3158
24. Raab de Verdugo U, Selinka H-C, Huber M, Kramer B, Kellermann J, Hofschneider PH, Kandolf R (1995) Characterization of a 100-kd binding protein for the six serotypes of coxsackie B viruses. J Virol 69:6751-6757
25. Schmidtke M, Selinka H-C, Heim A, Jahn B, Tonew M, Kandolf R, Stelzner A, Zell R (2000) Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology 275:77-88
26. Selinka H-C, Wolde A, Pasch A, Klingel K, Schnorr JJ, Kupper JH, Lindberg AM, Kandolf R (2002) Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis. J Med Virol 67:224-233
27. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD (1995) Coxsackieviruses B1, B3, and B5 use decay-accelerating factor as a receptor for cell attachment. J Virol 69:3873-3877
28. Shieh JT, Bergelson JM (2002) Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J Virol 76:9474-9480
29. Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94:3352-3356
30. Tracy S, Höfling K, Pirrucello S, Lane PH, Reyna SM, Gauntt CJ (2000) Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 62:70-81
31. Wolf JL, Rubin DH, Finberg R, Kauffman RS, Sharpe AH, Trier JS, Fields BN (1981) Intestinal M cells: a pathway for entry of reovirus into the host. Science 212:471-472
32. Zhang H, Blake NW, OuYang X, Pandolfino YA, Morgan-Capner P, Archard LC (1995) A single amino acid in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model. Arch Virol 140:959-966